These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 12575622

  • 21. The potential impact of prophylaxis against bronchiolitis due to the respiratory syncytial virus in children with congenital cardiac malformations.
    Rackham OJ, Thorburn K, Kerr SJ.
    Cardiol Young; 2005 Jun; 15(3):251-5. PubMed ID: 15865826
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Palivizumab in the prophylaxis of respiratory syncytial virus infection.
    Cardenas S, Auais A, Piedimonte G.
    Expert Rev Anti Infect Ther; 2005 Oct; 3(5):719-26. PubMed ID: 16207163
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The European Forum for Clinical Management: prophylaxis against the respiratory syncytial virus in infants and young children with congenital cardiac disease.
    Tulloh RM, Feltes TF.
    Cardiol Young; 2005 Jun; 15(3):274-8. PubMed ID: 15865829
    [Abstract] [Full Text] [Related]

  • 26. Economic analysis of palivizumab in infants with congenital heart disease.
    Yount LE, Mahle WT.
    Pediatrics; 2004 Dec; 114(6):1606-11. PubMed ID: 15574622
    [Abstract] [Full Text] [Related]

  • 27. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002.
    Henckel E, Luthander J, Berggren E, Kapadia H, Naver L, Norman M, Bennet R, Eriksson M.
    Pediatr Infect Dis J; 2004 Jan; 23(1):27-31. PubMed ID: 14743042
    [Abstract] [Full Text] [Related]

  • 28. [Humanized respiratory syncytial virus monoclonal antibody].
    Tsutsumi H.
    Nihon Rinsho; 2002 Mar; 60(3):487-91. PubMed ID: 11904963
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab.
    Mitchell I, Tough S, Gillis L, Majaesic C.
    Pediatr Pulmonol; 2006 Dec; 41(12):1167-74. PubMed ID: 17058279
    [Abstract] [Full Text] [Related]

  • 33. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis.
    Heikkinen T, Valkonen H, Lehtonen L, Vainionpää R, Ruuskanen O.
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F64-8. PubMed ID: 15613580
    [Abstract] [Full Text] [Related]

  • 34. Severe respiratory syncytial virus bronchiolitis: epidemiologic variations associated with the initiation of palivizumab in severely premature infants with bronchopulmonary dysplasia.
    Grimaldi M, Gouyon B, Michaut F, Huet F, Gouyon JB, Burgundy Perinatal Network.
    Pediatr Infect Dis J; 2004 Dec; 23(12):1081-5. PubMed ID: 15626942
    [Abstract] [Full Text] [Related]

  • 35. [Respiratory syncytial virus infection in high-risk infants].
    Adamovich K.
    Orv Hetil; 2001 Mar 18; 142(11):557-60. PubMed ID: 11305233
    [Abstract] [Full Text] [Related]

  • 36. [Methodological aspects of economic evaluation in pediatrics: illustration by RSV infection prophylaxis in the French setting].
    Hascoet JM, Fagnani F, Charlemagne A, Vieux R, Rozé JC, Bendjenana H.
    Arch Pediatr; 2008 Dec 18; 15(12):1739-48. PubMed ID: 18990549
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.
    Committee on Infectious Diseases.
    Pediatrics; 2009 Dec 18; 124(6):1694-701. PubMed ID: 19736258
    [Abstract] [Full Text] [Related]

  • 40. [Guidelines for respiratory syncytial virus prophylaxis. An update].
    Carbonell-Estrany X, Quero Jiménez J.
    An Esp Pediatr; 2002 Apr 18; 56(4):334-6. PubMed ID: 11927077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.